These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 36312783)

  • 1. Mechanism-driven strategies for prevention of rheumatoid arthritis.
    Holers VM; Kuhn KA; Demoruelle MK; Norris JM; Firestein GS; James EA; Robinson WH; Buckner JH; Deane KD
    Rheumatol Autoimmun; 2022 Sep; 2(3):109-119. PubMed ID: 36312783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are there causal mucosal drivers in the preclinical development of rheumatoid arthritis?
    Holers VM
    Semin Arthritis Rheum; 2024 Feb; 64S():152324. PubMed ID: 38030540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-RA: Can early diagnosis lead to prevention?
    Haville S; Deane KD
    Best Pract Res Clin Rheumatol; 2022 Mar; 36(1):101737. PubMed ID: 34991984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to Citrullinated Protein Antigens, Rheumatoid Factor Isotypes and the Shared Epitope and the Near-Term Development of Clinically-Apparent Rheumatoid Arthritis.
    Bergstedt DT; Tarter WJ; Peterson RA; Feser ML; Parish MC; Striebich CC; Demoruelle MK; Moss L; Bemis EA; Norris JM; Holers VM; Edison JD; Thiele GM; Mikuls TR; Deane KD
    Front Immunol; 2022; 13():916277. PubMed ID: 35812446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical Rheumatoid Arthritis and Rheumatoid Arthritis Prevention.
    Deane KD
    Curr Rheumatol Rep; 2018 Jun; 20(8):50. PubMed ID: 29946747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical rheumatoid arthritis and rheumatoid arthritis prevention.
    Greenblatt HK; Kim HA; Bettner LF; Deane KD
    Curr Opin Rheumatol; 2020 May; 32(3):289-296. PubMed ID: 32205569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies in inflammatory arthritis.
    Conigliaro P; Chimenti MS; Triggianese P; Sunzini F; Novelli L; Perricone C; Perricone R
    Autoimmun Rev; 2016 Jul; 15(7):673-83. PubMed ID: 26970491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement and its environmental determinants in the progression of human rheumatoid arthritis.
    Bemis EA; Norris JM; Seifert J; Frazer-Abel A; Okamoto Y; Feser ML; Demoruelle MK; Deane KD; Banda NK; Holers VM
    Mol Immunol; 2019 Aug; 112():256-265. PubMed ID: 31207549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis.
    Sokolove J; Bromberg R; Deane KD; Lahey LJ; Derber LA; Chandra PE; Edison JD; Gilliland WR; Tibshirani RJ; Norris JM; Holers VM; Robinson WH
    PLoS One; 2012; 7(5):e35296. PubMed ID: 22662108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pre-clinical phase of rheumatoid arthritis: From risk factors to prevention of arthritis.
    Petrovská N; Prajzlerová K; Vencovský J; Šenolt L; Filková M
    Autoimmun Rev; 2021 May; 20(5):102797. PubMed ID: 33746022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timing of Elevations of Autoantibody Isotypes Prior to Diagnosis of Rheumatoid Arthritis.
    Kelmenson LB; Wagner BD; McNair BK; Frazer-Abel A; Demoruelle MK; Bergstedt DT; Feser ML; Moss LK; Parish MC; Mewshaw EA; Mikuls TR; Edison JD; Holers VM; Deane KD
    Arthritis Rheumatol; 2020 Feb; 72(2):251-261. PubMed ID: 31464042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Natural History of Rheumatoid Arthritis.
    Deane KD; Holers VM
    Clin Ther; 2019 Jul; 41(7):1256-1269. PubMed ID: 31196652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of anti-citrullinated protein antibodies and rheumatoid factor is associated with increased systemic inflammatory mediators and more rapid progression from preclinical to clinical rheumatoid arthritis.
    Lingampalli N; Sokolove J; Lahey LJ; Edison JD; Gilliland WR; Holers VM; Deane KD; Robinson WH
    Clin Immunol; 2018 Oct; 195():119-126. PubMed ID: 29842946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of autoantibodies in "seronegative" rheumatoid arthritis associates with classical risk factors and high disease activity.
    Reed E; Hedström AK; Hansson M; Mathsson-Alm L; Brynedal B; Saevarsdottir S; Cornillet M; Jakobsson PJ; Holmdahl R; Skriner K; Serre G; Alfredsson L; Rönnelid J; Lundberg K
    Arthritis Res Ther; 2020 Jul; 22(1):170. PubMed ID: 32678001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rheumatoid arthritis, as a clinical disease, but not rheumatoid arthritis-associated autoimmunity, is linked to cardiovascular events.
    Gouze H; Aegerter P; Said-Nahal R; Zins M; Goldberg M; Morelle G; Schett G; Breban M; D'Agostino MA
    Arthritis Res Ther; 2022 Feb; 24(1):56. PubMed ID: 35209936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does information on novel identified autoantibodies contribute to predicting the progression from undifferentiated arthritis to rheumatoid arthritis: a study on anti-CarP antibodies as an example.
    Boeters DM; Trouw LA; van der Helm-van Mil AHM; van Steenbergen HW
    Arthritis Res Ther; 2018 May; 20(1):94. PubMed ID: 29724250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical rheumatoid arthritis (autoantibodies): an updated review.
    Deane KD
    Curr Rheumatol Rep; 2014 May; 16(5):419. PubMed ID: 24643396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
    Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosa Biology and the Development of Rheumatoid Arthritis: Potential for Prevention by Targeting Mucosal Processes.
    Demoruelle MK
    Clin Ther; 2019 Jul; 41(7):1270-1278. PubMed ID: 31196643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local Joint inflammation and histone citrullination in a murine model of the transition from preclinical autoimmunity to inflammatory arthritis.
    Sohn DH; Rhodes C; Onuma K; Zhao X; Sharpe O; Gazitt T; Shiao R; Fert-Bober J; Cheng D; Lahey LJ; Wong HH; Van Eyk J; Robinson WH; Sokolove J
    Arthritis Rheumatol; 2015 Nov; 67(11):2877-87. PubMed ID: 26227989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.